CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin gains.

CVS Health beats on Q2 earnings and raises 2025 EPS outlook, lifting shares nearly 8% on strong segment growth and margin gains.

CCK beats Q2 earnings and revenue estimates, lifts full-year EPS outlook on strong beverage segment growth.

CCK beats Q2 earnings and revenue estimates, lifts full-year EPS outlook on strong beverage segment growth.

ABBV tops Q2 forecasts and lifts 2025 EPS outlook as Rinvoq and Skyrizi drive growth amid Humira's decline.

ABBV tops Q2 forecasts and lifts 2025 EPS outlook as Rinvoq and Skyrizi drive growth amid Humira's decline.

NET beats Q2 earnings and revenue estimates, driven by enterprise growth and security demand. NET Raises full-year outlook on strong momentum.

NET beats Q2 earnings and revenue estimates, driven by enterprise growth and security demand. NET Raises full-year outlook on strong momentum.

RTX Q2 earnings and sales beat estimates on broad segment growth. However, the company trims its 2025 EPS forecast.

VMI's second-quarter profit and revenues beat estimates. Full-year EPS outlook is up, factoring in the impacts of the realignment actions.